Doç. Dr. Dicle İSKENDER

1. Impact of Dyslipidemia on Allogeneic Transplantation Outcomes and Cardiovascular Mortality in Patients with Acute Leukemias in the Post-Transplant Cyclophosphamide Era

Seçilmiş S., Aslan Candır B., Hatipoğlu U., Seyhan M., Uncu Ulu B., YİĞENOĞLU T. N., et al.

Pharmaceuticals , cilt.19, sa.4, 2026 (SCI-Expanded, Scopus)

2. Cladribine Treatment Outcomes in Hairy Cell Leukemia: A Single-center Experience

Seçilmiş S., Candır B. A., Yaman S., Bozan E., Ulu B. U., YİĞENOĞLU T. N., et al.

Acta Haematologica Oncologica Turcica , cilt.58, sa.3, ss.212-217, 2025 (Scopus, TRDizin)

3. Characteristics and Outcomes of Patients with Acute Promyelocytic Leukemia: A Single-center Experience

Seçilmiş S., Candır B. A., Bozan E., Yaman S., Ulu B. U., YİĞENOĞLU T. N., et al.

Acta Haematologica Oncologica Turcica , cilt.58, sa.2, ss.143-149, 2025 (Scopus, TRDizin)

4. Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias

Karakus A., TOPTAŞ T., DAL M. S., Durdu A., Hatipoglu U., Kayer M. A., et al.

Bone Marrow Transplantation , cilt.60, sa.6, ss.864-872, 2025 (SCI-Expanded, Scopus)

5. Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilization

Bakırtaş M., Ulu B. U., YİĞENOĞLU T. N., BAŞCI S., Kılınç A., Darçın T., et al.

Hematology, Transfusion and Cell Therapy , cilt.47, sa.1, 2025 (ESCI, Scopus)

6. Postoperative care in the caesarean intensive care unit: experience from a tertiary maternity hospital

Ergani S. Y., İSKENDER D., Aksan A., İbanoğlu M. C., Çakır B. T., KINAY T., et al.

Journal of the Turkish German Gynecology Association , cilt.24, sa.1, ss.42-47, 2023 (ESCI, Scopus, TRDizin)

7. Could blood groups have prognostic significance on survival in patients with diffuse large B cell lymphoma?

Ulu B. U., BAŞCI S., Bakırtaş M., YİĞENOĞLU T. N., BATGİ H., YILDIZ J., et al.

Leukemia Research , cilt.115, 2022 (SCI-Expanded, Scopus)

8. Pregnancy outcomes in female cancer survivors after hematopoietic stem cell transplantation

İSKENDER D., Ibanoǧlu M., Seçilmiş S., Baysal N., KIZIL ÇAKAR M., Dal M., et al.

European Review for Medical and Pharmacological Sciences , cilt.26, sa.3, ss.996-1003, 2022 (SCI-Expanded, Scopus)

9. Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience

Seçilmiş S., İSKENDER D., Candir B., Bozan E., Yaman S., Ulu B., et al.

European Review for Medical and Pharmacological Sciences , cilt.26, sa.10, ss.3487-3492, 2022 (SCI-Expanded, Scopus)

10. High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors

YILDIZ J., Ulu B. U., YİĞENOĞLU T. N., BAŞCI S., Bakirtas M., Sahin D., et al.

Journal of B.U.ON. , cilt.26, sa.6, ss.2531-2536, 2021 (SCI-Expanded, Scopus)

11. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma

Ulu B. U., YİĞENOĞLU T. N., BAŞCI S., Bakırtaş M., Şahin D., Darçın T., et al.

Leukemia Research , cilt.110, 2021 (SCI-Expanded, Scopus)

12. Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center study

Merdin A., DAL M. S., KIZIL ÇAKAR M., Bahsi T., Düzkale N., YILDIZ J., et al.

Medicine (United States) , cilt.100, sa.41, 2021 (SCI-Expanded, Scopus)

13. Old is bad? The effect of age on peripheral stem cell mobilization and transplantation outcomes

BAŞCI S., Bakırtaş M., Uncu Ulu B., YİĞENOĞLU T. N., Yaman S., BATGİ H., et al.

Transfusion and Apheresis Science , cilt.60, sa.1, 2021 (SCI-Expanded, Scopus)

14. Is classical Hodgkin lymphoma a different disease in the elderly? A single-center retrospective cohort study

YILDIZ J., Ulu B., YİĞENOĞLU T. N., BAŞCI S., Darçin T., Bakirtaş M., et al.

European Review for Medical and Pharmacological Sciences , cilt.25, sa.10, ss.3655-3660, 2021 (SCI-Expanded, Scopus)

15. Neutrophil-to-lymphocyte ratios in pregnant women with familial mediterranean fever

Keles A., İSKENDER D., Yucel Celik O., DAĞDEVİREN G., Iskender C., ÇAĞLAR A. T., et al.

Bratislava Medical Journal , cilt.122, sa.4, ss.251-255, 2021 (SCI-Expanded, Scopus)

16. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience

BATGİ H., Merdin A., DAL M. S., KIZIL ÇAKAR M., YILDIZ J., BAŞCI S., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.8, ss.1857-1863, 2020 (SCI-Expanded, Scopus)

17. Association between basal proteinuria levels and pregnancy outcomes in familial Mediterranean fever

İSKENDER D., KARA Ö., Ozturk Kaymak A., Daglar H., KIRBAŞ A., Iskender C., et al.

Journal of Obstetrics and Gynaecology , cilt.40, sa.8, ss.1102-1105, 2020 (SCI-Expanded, Scopus)

18. Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor

Merdin A., KIZIL ÇAKAR M., DAL M. S., MERT D., YILDIZ J., BAŞCI S., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.4, ss.929-932, 2020 (SCI-Expanded, Scopus)

19. Inferior prognosis in poor mobilizing myeloma patients

YİĞENOĞLU T. N., BAŞCI S., Ulu B. U., Bakırtaş M., Kılınç A., Şahin D., et al.

Transfusion and Apheresis Science , cilt.59, sa.3, 2020 (SCI-Expanded, Scopus)

20. The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors

YİĞENOĞLU T. N., BAŞCI S., Bakırtaş M., Ulu B. U., Kılınç A., Şahin D., et al.

Transfusion and Apheresis Science , cilt.59, sa.3, 2020 (SCI-Expanded, Scopus)

21. The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma

KIZIL ÇAKAR M., Tekgündüz E., Dal M. S., Merdin A., BAŞCI S., Uğur B., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.2, ss.273-278, 2020 (SCI-Expanded, Scopus)

22. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations

Merdin A., DAL M. S., KIZIL ÇAKAR M., YILDIZ J., Ulu B. U., BATGİ H., et al.

Medicine (United States) , cilt.99, sa.14, 2020 (SCI-Expanded, Scopus)

23. Hepatitis B virus reactivation under ibrutinib treatment in a patient with chronic lymphocytic leukemia Kronik lenfositik lösemili bir hastada ibrutinib tedavisi altında hepatit B virüsü reaktivasyonu

İSKENDER G., İSKENDER D., ERTEK M.

Turkish Journal of Hematology , cilt.37, sa.3, ss.208-209, 2020 (SCI-Expanded, Scopus, TRDizin)

24. The Outcome of Autologous Stem Cell Transplantation in Adolescent and Young Adult Patients with Multiple Myeloma

YİĞENOĞLU T. N., BAŞCI S., Ulu B. U., Bakirtas M., Sahin D., Darcin T., et al.

Eurasian Journal of Medicine and Oncology , cilt.4, sa.1, ss.79-83, 2020 (ESCI, Scopus, TRDizin)

25. Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

NAMDAROĞLU S., Kaya A. H., BATGİ H., Kayikci O., DAL M. S., İSKENDER D., et al.

Scientific Reports , cilt.9, sa.1, 2019 (SCI-Expanded, Scopus)

26. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies

MERT D., ÇEKEN S., İSKENDER G., İSKENDER D., Merdin A., Duygu F., et al.

Journal of Infection in Developing Countries , cilt.13, sa.8, ss.727-735, 2019 (SCI-Expanded, Scopus)

27. Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment

Merdin A., İSKENDER D., Ulu B. U., Doğan M., KIZIL ÇAKAR M., DAL M. S., et al.

Medicine , cilt.98, sa.30, 2019 (SCI-Expanded, Scopus)